CIPLA LTD.

Rolimus

ROLIMUS contains Drug / Molecule called “Everilomus”. Everolimus, an immunosuppressive drug, is prescribed for the management of graft rejection in graft versus host disease (GVHD) in organ transplanted patients. It belongs to a class of medications called as protein kinase inhibitor. Everolimus is a potent inhibitor of the growth and proliferation of tumour cells, has shown to reduce glycolysis.

Details
Specification

Indication

Rolimus is an immuno-suppressant which is used in kidney, liver, and heart transplant patients.

Note

Precaution

Rolimus is a prescription drug and should be used under proper medical guidance and advice.
Contraindicated in patients with clinical history of melanoma, clotting disorders, hepatic diseases.

Updated On Oct 21, 2019 by Admin